Table 3.
Multivariate Significance Analysis
| Clinical Feature | CR | NR | P Value | ||
|---|---|---|---|---|---|
| Multivariate analysis of cluster A with CR and NR (n = 56) | |||||
| FIGO stage | IB2/IIA/IIB | 35 | 7 | P = .664 | Not significantly |
| IIIA/IIIB | 13 | 1 | |||
| Tumor size | < 4 cm | 26 | 1 | P = .052 | Not significantly |
| ≥ 4 cm | 22 | 7 | |||
| HPV infection | Single | 40 | 5 | P = .181 | Not significantly |
| Co-infection | 8 | 3 | |||
| Multivariate analysis of cluster B with CR and NR (n = 33) | |||||
| FIGO stage | IB2/IIA/IIB | 18 | 8 | P = 0.026 | Significantly |
| IIIA/IIIB | 1 | 6 | |||
| Tumor size | < 4 cm | 7 | 1 | P ≤ .098 | Not significantly |
| ≥ 4 cm | 12 | 13 | |||
| HPV infection | Single | 12 | 9 | P = 1.000 | Not significantly |
| Co-infection | 7 | 5 | |||
P Values for stage, tumor size, and HPV co-infection were calculated by Fisher exact test.